Jcic Asset Management Inc. Eli Lilly & CO Transaction History

Jcic Asset Management Inc.

$228 Million
Q2 2024

A detailed history of Jcic Asset Management Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Jcic Asset Management Inc. holds 4,174 shares of LLY stock, worth $3.86 Million. This represents 1.66% of its overall portfolio holdings.

Number of Shares

4,174

Previous 4,195 0.5%

Holding current value

$3.86 Million

Previous $3.26 Million 15.81%

% of portfolio

1.66%

Previous 1.44%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 10, 2024	SELL	$724.87 - $909.04 $15,222 - $19,089	-21 Reduced 0.5%	4,174 $3.78 Million
Q1 2024 May 06, 2024	BUY	$592.2 - $792.28 $2.46 Million - $3.3 Million	4,160 Added 11885.71%	4,195 $3.26 Million
Q4 2023 Jan 16, 2024	SELL	$525.19 - $619.13 $7,877 - $9,286	-15 Reduced 30.0%	35 $20,000
Q3 2023 Oct 11, 2023	SELL	$434.7 - $599.3 $4,347 - $5,993	-10 Reduced 16.67%	50 $26,000
Q2 2023 Jul 19, 2023	SELL	$350.74 - $468.98 $1,753 - $2,344	-5 Reduced 7.69%	60 $28,000
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $29,648 - $33,787	-100 Reduced 60.61%	65 $24,000
Q2 2022 Jun 07, 2022	SELL	$278.73 - $327.27 $4,180 - $4,909	-15 Reduced 8.33%	165 $53,000
Q4 2021 Jan 19, 2022	BUY	$224.85 - $279.04 $14,615 - $18,137	65 Added 56.52%	180 $50,000
Q1 2021 Apr 14, 2021	BUY	$164.32 - $212.72 $18,896 - $24,462	115 New	115 $21,000
Q3 2019 Oct 07, 2019	SELL	$106.79 - $116.16 $3.75 Million - $4.08 Million	-35,111 Closed	0 $0
Q2 2019 Jul 15, 2019	SELL	$110.79 - $129.32 $21,604 - $25,217	-195 Reduced 0.55%	35,111 $3.89 Million
Q1 2019 Apr 12, 2019	BUY	$111.31 - $131.02 $3.93 Million - $4.63 Million	35,306 New	35,306 $4.58 Million

Others Institutions Holding LLY

# of Institutions

3,868

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $879B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jcic Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jcic Asset Management Inc. with notifications on news.

Account

Jcic Asset Management Inc. Eli Lilly & CO Transaction History